Anti-Covid nasal spray in approval queue could be game changer for India: Scientist - PowerPoint PPT Presentation

About This Presentation
Title:

Anti-Covid nasal spray in approval queue could be game changer for India: Scientist

Description:

SaNOtize is planning to submit emergency use functions to regulatory authorities within the UK and Canada for the therapy and prevention of Covid-19. Read more: – PowerPoint PPT presentation

Number of Views:22

less

Transcript and Presenter's Notes

Title: Anti-Covid nasal spray in approval queue could be game changer for India: Scientist


1
Welcome
2
Anti-Covid nasal spray in approval queue could be
game changer for India Scientist
3
Canada-based pharmaceutical agency SaNOtize has
filed for emergency approval in the UK and Canada
for its nitric oxide nasal spray. The
corporate says that the spray kills 99.9 percent
of the virus that causes Covid-19 and has
no confirmed negative effects.
4
(No Transcript)
5
SaNOtize, a Canada-based pharmaceutical agency,
has sought emergency approval from the UK and
Canada for using its nitric oxide nasal
spray. The corporate claims that the nasal
spray can be utilized as an efficient therapy for
Covid-19 because it kills 99.9 per cent of the
virus.
6
(No Transcript)
7
A self-administered nitric oxide nasal spray
(NONS) made by Vancouver-based biotech agency SaNO
tize has been discovered to dramatically cut
back Covid-19 viral load in contaminated sufferers
 after finishing early-stage medical trials in
Canada and, most just lately, the UK.
8
Thank You
Write a Comment
User Comments (0)
About PowerShow.com